Dermata Therapeutics, Inc. Logo

Dermata Therapeutics, Inc.

Medical dermatology company developing and commercializing OTC skin care products.

DRMA | US

Overview

Corporate Details

ISIN(s):
US2498451085
LEI:
Country:
United States of America
Address:
3525 DEL MAR HEIGHTS RD., #322, 92130 SAN DIEGO

Description

Dermata Therapeutics is a medical dermatology company that has shifted its strategic focus to developing and commercializing scientifically-backed over-the-counter (OTC) pharmaceutical products. The company leverages its proprietary Spongilla technology, which combines natural elements with FDA-listed OTC ingredients to create differentiated skin care solutions. Its initial product is a once-weekly acne kit, supported by clinical validation from its Phase 3 START-1 trial. Dermata plans to expand its portfolio with product candidates for other common skin conditions, such as psoriasis and seborrheic dermatitis, aiming to provide patients with accessible and effective treatments to manage their skin health.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Dermata Therapeutics, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Dermata Therapeutics, Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Dermata Therapeutics, Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

JW PHARMACEUTICAL Logo
Develops and commercializes pharmaceuticals, OTC solutions, and nutritional infusions.
South Korea
001060
JW SHINYAK CORPORATION Logo
Develops and sells medicines, specializing in dermatology and urology treatments.
South Korea
067290
Jyong Biotech Ltd. Logo
Develops plant-derived drugs for urinary system diseases, with a drug in Phase III.
United States of America
MENS
kainos loboratories,inc Logo
Develops and manufactures in-vitro diagnostics and clinical testing reagents.
Japan
4556
KAKEN PHARMACEUTIAL CO., LTD. Logo
Develops and markets pharmaceuticals for dermatology, orthopedics, and surgery.
Japan
4521
KALA BIO, Inc. Logo
Clinical-stage biopharma developing therapies for rare and severe eye diseases.
United States of America
KALA
Kalaris Therapeutics, Inc. Logo
Clinical-stage biopharmaceutical company developing treatments for retinal diseases.
United States of America
KLRS
KalVista Pharmaceuticals, Inc. Logo
Develops oral therapies for rare diseases, with a primary focus on HAE.
United States of America
KALV
Kamada Ltd. Logo
A biopharmaceutical company specializing in plasma-derived protein therapeutics.
Israel
KMDA
KAMADA LTD Logo
A biopharmaceutical company focused on specialty plasma-derived therapeutics.
United States of America
KMDA

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.